National Institutes of Health Consensus Development Conference: Management of hepatitis C: 2002

被引：180

作者：

Seeff, LB ^{[1
]}

Hoofnagle, JH ^{[1
]}

机构：

[1] NIDDKD, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA

来源：

HEPATOLOGY | 2002年 / 36卷 / 05期

关键词：

D O I：

10.1053/jhep.2002.36992

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S1 / S2

页数：2

共 5 条

[1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].

Alter, MJ ;

Kruszon-Moran, D ;

Nainan, OV ;

McQuillan, GM ;

Gao, FX ;

Moyer, LA ;

Kaslow, RA ;

Margolis, HS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562

[2] The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States [J].

Armstrong, GL ;

Alter, MJ ;

McQuillan, GM ;

Margolis, HS .

HEPATOLOGY, 2000, 31 (03) :777-782

[3]

Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296

[4] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].

Manns, MP ;

McHutchison, JG ;

Gordon, SC ;

Rustgi, VK ;

Shiffman, M ;

Reindollar, R ;

Goodman, ZD ;

Koury, K ;

Ling, MH ;

Albrecht, JK .

LANCET, 2001, 358 (9286) :958-965

[5]

*NAT I HLTH CONS D, 1997, HEPATOLOGY S1, V26, pS1

← 1 →